Skip to content

ONCORADIOMICS: what changed

BE 0662.719.440NACE 72.101, Research and development on biotechnologyOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€284,677
2024 · -€1.2m+€1.4m
Equity
-€3,807
2024 · -€1.0m+€1.0m
Cash
€8,698
2024 · €1.0m-€994,239
Balance sheet total
€4.3m
2024 · €3.8m+€506,653

Largest movements

2024 to 2025
Assets
  • Intangible fixed assets +€1.3m

    up €1.3m (+77.6%), from €1.7m to €3.0m

  • Cash -€994,239

    down €994,239 (-99.1%), from €1.0m to €8,698

    mainly Investment in fixed assets (net) (-€1.7m) and Debts after one year (-€633,970)

  • Receivables within one year +€307,046

    up €307,046 (+36.3%), from €845,374 to €1.2m

    of which Other amounts receivable: +€190,771

  • Deferred charges and accrued income -€106,676

    down €106,676 (-77.1%), from €138,424 to €31,748

Equity and liabilities
  • Investment grants +€733,762

    up €733,762 (+79.0%), from €928,835 to €1.7m

  • Debts after one year -€633,970

    down €633,970 (-45.2%), from €1.4m to €769,108

  • Trade debts +€494,018

    up €494,018 (+94.1%), from €524,739 to €1.0m

  • Accrued charges and deferred income -€443,136

    down €443,136 (-77.3%), from €572,937 to €129,800

  • Profit (loss) carried forward +€284,677

    up €284,677 (+5.3%), from -€5.4m to -€5.1m

Income statement
  • Gross operating margin +€1.1m

    up €1.1m (+87.8%), from €1.3m to €2.4m

  • Depreciation -€233,851

    down €233,851 (-34.3%), from €681,501 to €447,651

  • Financial charges -€53,875

    down €53,875 (-29.7%), from €181,422 to €127,546

  • Staff costs -€53,844

    down €53,844 (-3.4%), from €1.6m to €1.5m

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 -€1.2m
Gross operating margin +€1.1m
Staff costs +€53,844
Depreciation +€233,851
Other operating charges +€1,999
Other operating items -€3,423
Financial income +€1,247
Financial charges +€53,875
Taxes -€12,314
Result 2025 €284,677
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€553,351
Investment -€1.7m
Financing +€200,582
Cash 2024 €1.0m
Net result for the year +€284,677
Depreciation +€447,651
Receivables within one year -€307,046
Deferred charges and accrued income +€106,676
Trade debts +€494,018
Tax, wage and social debts -€29,488
Accrued charges and deferred income -€443,136
Investment in fixed assets (net) -€1.7m
Debts after one year -€633,970
Current portion of long-term debt +€58,526
Short-term financial debts +€42,265
Contributions, distributions and other +€733,762
Cash 2025 €8,698
brings cash intakes cash out
Every line side by side 50 lines
Line Code 2024 2025 Change %
Total assets 20/58 €3,800,107 €4,306,760 +€506,653 +13.3%
Fixed assets 21/28 €1,813,371 €3,113,892 +€1.3m +71.7%
Intangible fixed assets 21 €1,704,814 €3,028,236 +€1.3m +77.6%
Tangible fixed assets 22/27 €37,072 €14,171 -€22,900 -61.8%
Furniture and vehicles 24 €32,013 €11,996 -€20,016 -62.5%
Other tangible fixed assets 26 €5,059 €2,175 -€2,884 -57.0%
Financial fixed assets 28 €71,485 €71,485 = 0.0%
Current assets 29/58 €1,986,736 €1,192,867 -€793,869 -40.0%
Amounts receivable within one year 40/41 €845,374 €1,152,421 +€307,046 +36.3%
Trade receivables 40 €556,060 €672,335 +€116,275 +20.9%
Other amounts receivable 41 €289,314 €480,086 +€190,771 +65.9%
Cash at bank and in hand 54/58 €1,002,938 €8,698 -€994,239 -99.1%
Deferred charges and accrued income 490/1 €138,424 €31,748 -€106,676 -77.1%
Total equity and liabilities 10/49 €3,800,107 €4,306,760 +€506,653 +13.3%
Equity 10/15 -€1,022,246 -€3,807 +€1.0m +99.6%
Contributions 10/11 €3,469,744 €3,469,744 = 0.0%
Capital 10 €270,428 €270,428 = 0.0%
Issued capital 100 €270,428 €270,428 = 0.0%
Contributions outside capital 11 €3,199,316 €3,199,316 = 0.0%
Share premium 1100/10 €3,199,316 €3,199,316 = 0.0%
Profit (loss) carried forward 14 -€5,420,824 -€5,136,147 +€284,677 +5.3%
Investment grants 15 €928,835 €1,662,596 +€733,762 +79.0%
Amounts payable 17/49 €4,822,353 €4,310,567 -€511,786 -10.6%
Amounts payable after more than one year 17 €1,403,079 €769,108 -€633,970 -45.2%
Financial debts 170/4 €1,403,079 €769,108 -€633,970 -45.2%
Amounts payable within one year 42/48 €2,846,338 €3,411,659 +€565,321 +19.9%
Current portion of amounts payable after more than one year 42 €162,326 €220,852 +€58,526 +36.1%
Financial debts 43 €2,000,000 €2,042,265 +€42,265 +2.1%
Credit institutions 430/8 €2,000,000 €1,692,265 -€307,735 -15.4%
Other loans 439 - €350,000 +€350,000
Trade debts 44 €524,739 €1,018,758 +€494,018 +94.1%
Suppliers 440/4 €524,739 €1,018,758 +€494,018 +94.1%
Taxes, remuneration and social security 45 €159,272 €129,784 -€29,488 -18.5%
Taxes 450/3 €2,203 €1,156 -€1,048 -47.6%
Remuneration and social security 454/9 €157,068 €128,628 -€28,440 -18.1%
Accrued charges and deferred income 492/3 €572,937 €129,800 -€443,136 -77.3%
Remuneration, social security and pensions 62 €1,561,181 €1,507,337 -€53,844 -3.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €681,501 €447,651 -€233,851 -34.3%
Other operating charges 640/8 €2,019 €20 -€1,999 -99.0%
Non-recurring operating charges 66A €0 €3,423 +€3,423
Gross operating margin 9900 €1,261,343 €2,368,499 +€1.1m +87.8%
Operating profit (loss) 9901 -€983,359 €410,067 +€1.4m
Financial income 75/76B €909 €2,156 +€1,247 +137%
Recurring financial income 75 €909 €2,156 +€1,247 +137%
Financial charges 65/66B €181,422 €127,546 -€53,875 -29.7%
Recurring financial charges 65 €181,422 €127,546 -€53,875 -29.7%
Profit (loss) for the period before taxes 9903 -€1,163,871 €284,677 +€1.4m
Income taxes 67/77 -€12,314 €0 +€12,314
Profit (loss) for the period 9904 -€1,151,557 €284,677 +€1.4m
Profit (loss) for the period to be appropriated 9905 -€1,151,557 €284,677 +€1.4m

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

The filed figures and these assumptions give no positive value. The adjusted equity and the average result are both zero or negative.

Part of the calculation comes out below zero. A shareholding is never worth less than zero, so the floor is zero.

Adjusted equity -€3.0m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
-€3,807
Intangible fixed assets (21)
-€3,028,236
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
-€3.0m

Capitalised earnings

net result for the year (9904)
2025
€284,677
excluding non-recurring income and charges
€288,100
2024
-€1,151,557
2023
-€1,902,176
excluding non-recurring income and charges
-€1,890,976
2022
-€2,367,092
excluding non-recurring income and charges
-€2,362,231
2021
-€1,476,821
excluding non-recurring income and charges
-€1,472,602
Average result, excluding non-recurring income and charges
-€918,144
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 21 November 2026 via checked.be.